Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-12-05

Clinical Trial Update: Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Psoriasis

View source ↗

Summary

Observational post-marketing study assessing AbbVie's Humira effectiveness in psoriasis completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Humira (adalimumab)

Snippet

Sponsor: AbbVie (prior sponsor, Abbott) | Conditions: Psoriasis | Status: COMPLETED | Results posted: 2019-12-05